Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Neonatal Gallstones Serendipitously Discovered by Point-of-Care Ultrasound in the Pediatric Emergency Department.

Damman J, Doniger SJ, Atigapramoj N.

Pediatr Emerg Care. 2016 Feb 15. [Epub ahead of print]

PMID:
26890298
2.

New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.

Poppelaars F, Damman J, de Vrij EL, Burgerhof JG, Saye J, Daha MR, Leuvenink HG, Uknis ME, Seelen MA.

Clin Exp Immunol. 2016 Jun;184(3):378-88. doi: 10.1111/cei.12777. Epub 2016 Apr 13.

PMID:
26874675
3.

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation.

Shuker N, Bouamar R, van Schaik RH, Clahsen-van Groningen MC, Damman J, Baan CC, van de Wetering J, Rowshani AT, Weimar W, van Gelder T, Hesselink DA.

Am J Transplant. 2016 Jul;16(7):2085-96. doi: 10.1111/ajt.13691. Epub 2016 Feb 26.

PMID:
26714287
4.

Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.

Dessing MC, Kers J, Damman J, Leuvenink HG, van Goor H, Hillebrands JL, Hepkema BG, Snieder H, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Florquin S, Seelen M, Leemans JC.

PLoS One. 2015 Oct 7;10(10):e0139769. doi: 10.1371/journal.pone.0139769. eCollection 2015.

5.

Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.

Sin AT, Damman JL, Ziring DA, Gleghorn EE, Garcia-Careaga MG, Gugig RR, Hunter AK, Burgis JC, Bass DM, Park KT.

Inflamm Bowel Dis. 2015 Jun;21(6):1368-77. doi: 10.1097/MIB.0000000000000374.

6.

Renal expression of Toll-like receptor 2 and 4: dynamics in human allograft injury and comparison to rodents.

Stribos EG, van Werkhoven MB, Poppelaars F, van Goor H, Olinga P, van Son WJ, Damman J, Seelen MA.

Mol Immunol. 2015 Mar;64(1):82-9. doi: 10.1016/j.molimm.2014.11.003. Epub 2014 Nov 29.

PMID:
25465639
7.

Hypoxia and Complement-and-Coagulation Pathways in the Deceased Organ Donor as the Major Target for Intervention to Improve Renal Allograft Outcome.

Damman J, Bloks VW, Daha MR, van der Most PJ, Sanjabi B, van der Vlies P, Snieder H, Ploeg RJ, Krikke C, Leuvenink HG, Seelen MA.

Transplantation. 2015 Jun;99(6):1293-300. doi: 10.1097/TP.0000000000000500.

PMID:
25427168
8.

Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress.

Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M, Moser J, Hillebrands JL, Ploeg RJ, Yang G, Leuvenink HG, van Goor H.

J Am Soc Nephrol. 2013 Apr;24(5):759-70. doi: 10.1681/ASN.2012030268. Epub 2013 Feb 28.

9.

Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction.

van Werkhoven MB, Damman J, van Dijk MC, Daha MR, de Jong IJ, Leliveld A, Krikke C, Leuvenink HG, van Goor H, van Son WJ, Olinga P, Hillebrands JL, Seelen MA.

Am J Transplant. 2013 Apr;13(4):875-82. doi: 10.1111/ajt.12130. Epub 2013 Feb 7.

10.

Mannan binding lectin: a two-faced regulator of renal allograft injury?

Damman J, Seelen MA.

Kidney Int. 2013 Feb;83(2):191-3. doi: 10.1038/ki.2012.397.

PMID:
23364585
11.

Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.

de Vries DK, van der Pol P, van Anken GE, van Gijlswijk DJ, Damman J, Lindeman JH, Reinders ME, Schaapherder AF, Kooten Cv.

Transplantation. 2013 Mar 27;95(6):816-20. doi: 10.1097/TP.0b013e31827e31c9.

PMID:
23348894
12.

SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation.

Reznichenko A, Sinkeler SJ, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G.

Physiol Genomics. 2013 Mar 18;45(6):201-9. doi: 10.1152/physiolgenomics.00087.2012. Epub 2013 Jan 22.

13.

Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney.

van Werkhoven MB, Damman J, Daha MR, Krikke C, van Goor H, van Son WJ, Hillebrands JL, van Dijk MC, Seelen MA.

Mol Immunol. 2013 Mar;53(3):237-45. doi: 10.1016/j.molimm.2012.08.013. Epub 2012 Sep 6.

PMID:
22960554
14.

UMOD as a susceptibility gene for end-stage renal disease.

Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

BMC Med Genet. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78.

15.

CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.

Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

PLoS One. 2012;7(5):e36512. doi: 10.1371/journal.pone.0036512. Epub 2012 May 4.

16.

CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.

Muntinghe FL, Abdulahad WH, Huitema MG, Damman J, Seelen MA, Lems SP, Hepkema BG, Navis G, Westra J.

PLoS One. 2012;7(2):e31257. doi: 10.1371/journal.pone.0031257. Epub 2012 Feb 13.

17.

Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.

Damman J, Daha MR, Leuvenink HG, van Goor H, Hillebrands JL, Dijk MC, Hepkema BG, Snieder H, Born Jv, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA.

Am J Transplant. 2012 Mar;12(3):660-8. doi: 10.1111/j.1600-6143.2011.03880.x. Epub 2011 Dec 17.

18.

Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.

Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, Hepkema BG, Reznichenko A, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA.

Mol Immunol. 2012 Feb;50(1-2):1-8. doi: 10.1016/j.molimm.2011.11.009. Epub 2011 Dec 15.

PMID:
22173059
19.

Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.

Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ.

Transplantation. 2011 Jul 27;92(2):163-9. doi: 10.1097/TP.0b013e318222c9a0.

PMID:
21677599
20.

Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury.

Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA.

Am J Transplant. 2011 Apr;11(4):660-9. doi: 10.1111/j.1600-6143.2011.03475.x. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk